Crossmark Global Holdings, Inc. Edwards Lifesciences Corp Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 34,835 shares of EW stock, worth $2.36 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

34,835

Previous 41,452 15.96%

Holding current value

$2.36 Million

Previous $3.83 Million 39.96%

% of portfolio

0.04%

Previous 0.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$59.7 - $93.78 $395,034 - $620,542	-6,617 Reduced 15.96%	34,835 $2.3 Million
Q2 2024 Jul 29, 2024	SELL	$84.3 - $94.31 $6,996 - $7,827	-83 Reduced 0.2%	41,452 $3.83 Million
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $235,392 - $310,092	-3,245 Reduced 7.25%	41,535 $3.97 Million
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $215,676 - $271,771	-3,495 Reduced 7.24%	44,780 $3.42 Million
Q3 2023 Nov 08, 2023	BUY	$69.28 - $93.38 $35,402 - $47,717	511 Added 1.07%	48,275 $3.52 Million
Q2 2023 Jul 31, 2023	SELL	$81.41 - $94.33 $57,719 - $66,879	-709 Reduced 1.46%	47,764 $4 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $106,191 - $120,849	-1,430 Reduced 2.87%	48,473 $4.01 Million
Q4 2022 Jan 19, 2023	BUY	$68.3 - $87.44 $287,201 - $367,685	4,205 Added 9.2%	49,903 $3.72 Million
Q3 2022 Nov 01, 2022	SELL	$82.37 - $107.29 $25,452 - $33,152	-309 Reduced 0.67%	45,698 $3.78 Million
Q2 2022 Jul 29, 2022	SELL	$86.5 - $128.27 $1.52 Million - $2.26 Million	-17,594 Reduced 27.66%	46,007 $4.37 Million
Q1 2022 May 11, 2022	BUY	$101.96 - $128.34 $16,619 - $20,919	163 Added 0.26%	63,601 $7.49 Million
Q4 2021 Jan 10, 2022	SELL	$106.37 - $130.68 $122,644 - $150,674	-1,153 Reduced 1.79%	63,438 $8.22 Million
Q3 2021 Oct 21, 2021	BUY	$102.91 - $122.75 $3.12 Million - $3.72 Million	30,289 Added 88.3%	64,591 $7.31 Million
Q3 2021 Oct 13, 2021	SELL	$102.91 - $122.75 $3.91 Million - $4.66 Million	-37,983 Reduced 52.55%	34,302 $614,000
Q2 2021 Jul 21, 2021	SELL	$83.84 - $104.76 $130,035 - $162,482	-1,551 Reduced 2.1%	72,285 $7.49 Million
Q1 2021 Apr 15, 2021	SELL	$78.68 - $90.67 $68,687 - $79,154	-873 Reduced 1.17%	73,836 $6.18 Million
Q4 2020 Jan 14, 2021	SELL	$71.69 - $91.23 $661,698 - $842,052	-9,230 Reduced 11.0%	74,709 $6.82 Million
Q3 2020 Oct 08, 2020	BUY	$67.19 - $87.44 $14,580 - $18,974	217 Added 0.26%	83,939 $6.7 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $3.3 Million - $4.42 Million	57,395 Added 218.01%	83,722 $5.79 Million
Q1 2020 Apr 28, 2020	BUY	$52.41 - $81.0 $72,692 - $112,347	1,387 Added 5.56%	26,327 $1.66 Million
Q4 2019 Feb 06, 2020	SELL	$71.7 - $82.09 $65,820 - $75,358	-918 Reduced 3.55%	24,940 $5.82 Million
Q3 2019 Oct 09, 2019	BUY	$61.55 - $75.43 $429,926 - $526,878	6,985 Added 37.01%	25,858 $5.69 Million
Q2 2019 Jul 09, 2019	SELL	$55.74 - $64.41 $33,053 - $38,195	-593 Reduced 3.05%	18,873 $3.49 Million
Q1 2019 May 02, 2019	SELL	$47.89 - $64.05 $28,255 - $37,789	-590 Reduced 2.94%	19,466 $3.72 Million
Q4 2018 Jan 31, 2019	SELL	$46.41 - $56.94 $102,983 - $126,349	-2,219 Reduced 9.96%	20,056 $3.07 Million
Q3 2018 Nov 08, 2018	SELL	$45.7 - $58.03 $63,842 - $81,067	-1,397 Reduced 5.9%	22,275 $3.88 Million
Q2 2018 Jul 31, 2018	SELL	$42.45 - $51.3 $25,894 - $31,293	-610 Reduced 2.51%	23,672 $3.45 Million
Q1 2018 Apr 16, 2018	SELL	$37.19 - $47.45 $46,115 - $58,838	-1,240 Reduced 4.86%	24,282 $3.39 Million
Q4 2017 Feb 05, 2018	BUY	$33.79 - $39.39 $76,534 - $89,218	2,265 Added 9.74%	25,522 $2.88 Million
Q3 2016 Oct 25, 2017	BUY	N/A	23,257	23,257 $2.54 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Edwards Lifesciences Corp Transaction History